Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mivacurium vs rocuronium in minimally invasive endoscopic surgery
ChiCTR2500114258Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of mivacurium in neuromuscular block (NMB) (2 arms), sponsored by Second Affiliated Hospital of Guangzhou Medical University. Primary endpoints: Onset time, Reversal rate and 2 more. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
mivacurium
03
Conditions
neuromuscular block (NMB)
Beyond the preview
Go deeper on ChiCTR2500114258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114258.